Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Molecular Features
100%
COMPASS-like
100%
Poor Differentiation
33%
Gene Alteration
33%
Metastatic Pancreatic Ductal Adenocarcinoma
22%
TP53 mutation
22%
Therapeutic Implications
22%
Prognostic Implications
22%
Squamous Differentiation
22%
Loss Function
11%
Regulatory Genes
11%
Death Rate
11%
Molecular Profiling
11%
Tumor Protein p53 (TP53)
11%
Epigenetic Regulation
11%
Public Dataset
11%
Sequencing Studies
11%
Histopathological Features
11%
Genome-wide Sequencing
11%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
11%
SMAD4
11%
Undifferentiated Histology
11%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Gene Mutation
100%
Wild Type
33%
KRAS
33%
Epigenetics
33%
Mortality Rate
33%
Gene Control
33%
Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Cohort Analysis
27%
Gene Mutation
27%
Mortality Rate
9%
Gene Control
9%
Molecular Profiling
9%
Tail
9%